# An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

> **NCT07288320** · PHASE2 · RECRUITING · sponsor: **Neurocrine Biosciences** · enrollment: 150 (estimated)

## Conditions studied

- Bipolar I Disorder
- Mania

## Interventions

- **DRUG:** NBI-1117568
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07288320
- **Lead sponsor:** Neurocrine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-24
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07288320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07288320, "An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07288320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*